UK takes action to prevent API shortages
June 20, 2013Manufacturing and Production API, MHRA, shortages
The UK has unilaterally adopted a policy of allowing imports of active pharmaceutical ingredients (API) on the strength of pharmaceutical …
Sanofi makes Curie cancer deal
June 20, 2013Research and Development, Sales and Marketing Cancer, R&D, Sanofi, curie
Sanofi has signed a three-year research collaboration with the Curie Institute to identify new therapeutic targets which will help develop …
InHealthcare appoints NHS director
June 20, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing InHealthcare
Digital healthcare firm InHealthcare has appointed NHS director Simon Jones as its new commercial director.Jones has held positions in Acute Hospitals, Mental Health and …
Nine fined in EU pay-for-delay deals
June 20, 2013Manufacturing and Production, Sales and Marketing EU, Lundbeck, Merck, Ranbaxy
Nine pharma firms have been handed hefty fines by the European Commission over allegations that they willingly blocked generic versions …
CQC embroiled in ‘cover up’ row
June 20, 2013Sales and Marketing Mid Staffs, NHS. CQC, UHMB
The organisation responsible for inspecting health and care standards in the NHS is at the centre of a flaming political …
United Drug hires Abbott VP
June 19, 2013Manufacturing and Production, Research and Development, Sales and Marketing Abbott, United Drug
Healthcare services firm United Drug has appointed Brendan McAtamney as chief operating officer with effect from September. McAtamney will be …
GSK receives thrombosis offer
June 19, 2013Sales and Marketing GSK, aspen, thrombosis
GlaxoSmithKline has received an offer from South African firm Aspen Global Incorporated (AGI) to buy its injectable thrombosis treatments and …
Lilly pays Transition $7 million
June 19, 2013Research and Development, Sales and Marketing Transition, lilly
Eli Lilly is to take up its option to develop and commercialise a type 2 diabetes candidate, paying Canadian firm …
AstraZeneca chooses Cambridge for global HQ
June 19, 2013Research and Development, Sales and Marketing AstraZeneca, Cambridge, MedImmune
AstraZeneca has chosen the Cambridge Biomedical Campus on the outskirts of the city as a new research and corporate hub. …
Is Google Glass hospital ready?
June 19, 2013Medical Communications Google glass, langevin, venturebeat
Google Glass has the potential to greatly enhance medical practices in a number of ways. Among these is the ability to retrieve, …
DJM Digital Solutions appoints senior vice president
June 19, 2013Medical Communications, Sales and Marketing Creston, DJM
Digital healthcare agency DJM Digital Solutions has appointed Ray Manna as senior vice president, North America. Manna will report to …
Avastin gets GBM approval
June 18, 2013Research and Development, Sales and Marketing GBM, Roche, avastin
Roche has received a major boost with the first approval in early treatment of the most aggressive form of brain …
MedImmune signs diabetes deal
June 18, 2013Research and Development, Sales and Marketing AstraZeneca, MedImmune, diabetes
AstraZeneca R&D subsidiary MedImmune has signed a deal with privately-owned San Francisco-based NGM Biopharmaceuticals to discover novel therapeutics to treat …
J&J to pay up to $1 billion in Aragon deal
June 18, 2013Research and Development, Sales and Marketing Aragon, J&J, JJ, Zytiga
Johnson & Johnson could pay as much as $1 billion to buy prostate cancer specialist Aragon Pharmaceuticals. The acquisition includes …
Quality issues ‘leading cause of drug shortages’
June 18, 2013Manufacturing and Production ISPE, shortages
Shortages of key medicines have been increasing in recent years, and a new survey from the International Society for Pharmaceutical …
Cmed Group Showcases Trial Delivery Capabilities at DIA 2013
June 17, 2013Research and Development
Cmed Group will showcase its full-service CRO capabilities at the DIA’s Annual Meeting 2013 (June 23-27, 2013, Boston Convention and …
New ABPI director of communications announced
June 17, 2013Medical Communications, Research and Development, Sales and Marketing ABPI, Meadden, Whitehead
The ABPI has appointed its head of Policy and Public Affairs Catherine Meaden to be the organisation’s new director of …
Eisai’s £8 million UK expansion
June 17, 2013Manufacturing and Production Eisai
Eisai has decided to invest further into its Hertfordshire production plant in the UK towards the creation of an additional …
ICON appoints executive vice president
June 17, 2013Manufacturing and Production, Research and Development, Sales and Marketing ICON
Clinical research organisation ICON has appointed Dr Neil McCullough as executive vice president of Quality and Compliance and Corporate Training.McCullough …
John LaMattina: Pharma’s R&D deals with foundations may hit reputations
June 17, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing John LaMattina
On the surface, it sounds pretty reasonable. Foundations like the Michael J. Fox Foundation and the Cystic Fibrosis Foundation (CFF), …
Latest content
Pharma sees climate disruption as growing supply-chain risk
Manchester NHS-MHRA partnership to test new technologies in real-world care
